Evidence map›Paper›PMID 40688292›Full record

ArticleJournal of thoracic disease2025

Application of an advanced steerable microcatheter for challenging arterial embolization in massive hemoptysis.

Lu Liu, Qing-Hui Zeng, Zhong-Wei Zhao, Ri-Sheng Yu, Fa-Zong Wu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lu Liu *Cancer Center, Zhejiang University Lishui Hospital, Zhejiang Key Laboratory of Imaging and Interventional Medicine, Lishui Municipal Central Hospital, Lishui, China.ORCID https://orcid.org/0009-0007-8187-9166
Qing-Hui Zeng *Department of Cardiothoracic Surgery, Zhejiang University Lishui Hospital, Lishui Municipal Central Hospital, Lishui, China.
Zhong-Wei ZhaoCancer Center, Zhejiang University Lishui Hospital, Zhejiang Key Laboratory of Imaging and Interventional Medicine, Lishui Municipal Central Hospital, Lishui, China.
Ri-Sheng YuDepartment of Radiology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Fa-Zong WuCancer Center, Zhejiang University Lishui Hospital, Zhejiang Key Laboratory of Imaging and Interventional Medicine, Lishui Municipal Central Hospital, Lishui, China.ORCID https://orcid.org/0000-0001-5798-1848

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bronchial artery embolization (BAE) is a safe and effective treatment for hemoptysis, which is caused by diseases such as lung cancer, bronchiectasis, and tuberculosis. In cases of massive hemoptysis, the offending vessel originates from the bronchial artery in more than 90% of cases, and in a few cases, it can originate from nonbronchial arteries. Superselective embolization of complex or rarely affected vessels remains challenging. The SwiftNINJA

Indexed as

acute angulationbronchial artery embolization (BAE)Hemoptysissteerable microcatheter

Identifiers

PMID40688292
PMCPMC12268476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.